Previous ID Grand Rounds
2010
Professor of Radiology,
Director, Division of
Nuclear Medicine, UC
Denver
1/27/10
William
Klingensmith,
MD
Imaging Infection with FDG &
PET-CT: The Best Imaging
Study for Infection
2/10/10
Robert Belknap,
MD
Assistant Professor,
INFgamma Release Assays for
Division of Infectious
Diagnosis of TB
Diseases - UC Denver
2/17/10
3/3/10
3/10/10
3/31/10
4/7/10
5/5/10
Assistant Research
Scientist, Assistant
Professor Epidemiology
Department, Colorado
School of Public Health
Alia Al-Tayyib,
PhD
HIV Behavioral Surveillance
Project
Kevin High, MD
Professor of Medicine,
HIV and Aging: Pathogenesis,
Chief, Section of
Outcomes and Future
Infectious Diseases,
Research Priorities
Wake Forest University
Richard
Haubrach, MD
Regimens for Treatment
Experienced HIV-Infected
Patients: Which Agents, How
Many and Why (and How the
Resistance Test Can Help)
Carlos Del Rio,
MD
Professor/Chair - Hubert
Department of Global
Tim Gill Lecture Presentation: Health, Rollins School of
Sex, Drugs, and HIV: The
Public Health. Professor
Synergistic Epidemics of Crack of Medicine in Infectious
Cocaine and HIV
Diseases at the Emory
University School of
Medicine
Professor of Medicine,
Division of Infectious
Diseases, University of
California, San Diego, CA
Reuler-Lewin Family
Professor and Chair of
Neurology. Professor of
Medicine, Microbiology
and Immunology UC
Denver
Ken Tyler, MD
West Nile Virus Neuroinvasive
Disease
Marinka
Kartalija, MD
Characterizing Body
Morphotype and Serum
Fellow, Infectious
Adipokine & Cytokine Levels in
Diseases, UC Denver
Patients with Nontuberculosis
Mycobacteruak (NTM) Lung
Disease
The use of EBV Lytic and
Latency III mRNA and of Viral
DNA for Early Detention of
PTLD
Fellow, Infectious
Diseases, UC Denver
5/12/10
Jing Kroll, MD
6/2/10
Kristine
Erlandson, MD
Fellow, Infectious
Diseases, UC Denver
6/16/10
Margaret
McLees, MD
Fellow, Infectious
Diseases, UC Denver
2009
2/4/2009
Sam
MaWhinney,
PhD
4/1/2009
Trends in Shiga toxinAlicia Cronquist,
producing E. Coli (STEC)
RN, MPH
Infection
Statistics 101
Professor, Preventive
Medicine and
Biostatistics – UC Denver
Foodborne/Enteric
Disease Epidemiologist.
CO Dept. of Public Health
and Environment
Associate Professor,
Division of Hematology &
Oncology, UCLA David
Geffen School of
Medicine
5/6/2009
Beth Jamieson,
PhD
The Dual Impact of HIV and
Age on T-Cells; Why getting
HIV makes you old
6/3/2009
Vivian Cox, MD
HIV-1 Infection of Follicular
CD4+ Lymphocites
ID Fellow – UC Denver
8/12/2009
Mary Kestler,
MD
TB/HIV Education and Care
Program for Health Care
Workers in Botswana
Head, TB/HIV Program,
Botswana-University of
Pennsylvania
8/19/2009
Joshua
Metabolic Drug Targets in TB
Christensen, MD
Current Challenges and
Evolving Concepts in the
Management of Invasive
Fungal Infections in Solid
Organ Transplant Recipients
ID Fellow, UC Denver
Professor of Medicine,
Division of Infectious
Diseases, University of
Pittsburgh
9/9/2009
Nina Singh, MD
9/16/2009
Risk Factors of Clostridium
Eric Kajioka, MD Difficile Infection in
Hospitalized Adults
ID Fellow, UC Denver
9/30/2009
Charles
Steinberg, MD
Consultant and Trainer,
ID Institute
AIDS in Africa, One Colorado
Doctor’s Experience
11/11/2009 Dan Bausch, MD
Challenges to Diagnosis the
Viral Hemorrhagic Fevers
Associate Professor,
Department of Tropical
Medicine, Tulane School
of Public Health and
Tropical Medicine
2008
Date
Speaker
1/10/2008
Topic
HIV Lipoatrophy
Medical Director,
Associate Professor,
Department of
Dermatology, UC Denver
The Current Increase in
Syphillis
STD/HIV Section Chief,
CDPHE
Theresa
Pacheco, MD
1/17/2008
1/24/2008
Ralph Wilmoth
Pathogenic Mechanisms and
Antimicrobial Treatment of
Dennis Stevens,
Toxin Related Infections
MD, PhD
Caused by Gram Positive
Microbes
1/31/2008
David Margolis,
MD
2/14/2008
2/21/2008
3/6/2008
3/13/2008
William Claude
Klingensmith,
MD
Dan Kuritzes,
MD
3/20/2008
Professor of Medicine,
University of Washington
Mechanisms that Maintain HIV
Latency: Targets for Future
Therapeutics to Eradicate
Persistent Infection
Professor of Medicine,
Microbiology and
Immunology,
Epidemiology, University
Of North Carolina at
Chapel Hill
Imaging Infection with FDG &
PET-CT
Director, Hewit
Biomolecular Imaging
Center, Porter Hospital
HIV-1 Entry, Chemokine
Receptors, and CCR5
Antagonists
Glenn Treisman, HIV and Depression
MD, PhD
Thomas Gootz,
MD
Affiliation/Contact
Professor of Medicine,
Harvard Medical School
Director of HIV Mental
Health, Johns Hopkins
Carbapenem-Resistance in
Klebisiella Pneumoniae, a
Global Problem
Department of
Antibiotics, Immunology,
and Cancer, Pfizer
Hepatitis C
Professor of Medicine,
Division Head of
Gastroenterology, UC
Denver
Hugo Rosen, MD
4/10/2008
Edward
Gardner, MD
HIV and Medication
Adherence
Assistant Professor of ID,
UC Denver
4/17/2008
Rohini Sharma,
MD
Staphylococcus and Epidural
Abscesses
ID Fellow, UC Denver
5/1/2008
Rawleigh Howe,
MD
Dendritic Cells and HIV
5/15/2008
Minal Kapoor,
MD
Central Blood Stream
Infection Prevention
ID Fellow, UC Denver
ID Fellow, UC Denver
5/22/2008
6/5/2008
6/12/2008
6/18/2008
Daniel Musher,
MD
Timothy
Jenkins, MD
CA-MRSA USA300
Bloodstream Infections in
Denver’s Health Care System
Professor of Medicine,
Baylor University
ID Fellow, UC Denver
The Role of Antibiotics in
Carla Saveli, MD Open Fractures in the Era of
CA-MRSA
ID Fellow, UC Denver
Mary Kestler,
MD
Delays in the Diagnosis of
Tuberculosis
ID Fellow, UC Denver
Michelle Haas,
MD
HIV-1 Infection of
FollicularCD4+ cells may be
associated with increased BClID Fellow, University of
2 levels and affect cell
Colorado Denver
survival: Implications for
persistent viral replication in
lymphoid tissues
9/3/2008
10/1/2008
Syphillis
David Cohn, MD TB Infection Control in
Resource Limited Settings;
Can it Be Done?
Professor of Medicine,
Denver Health Hospital
Douglas Fish,
10/15/2008 PharmD
Antimicrobial
Pharmacodynamics:
Assessing the role of Monte
Carlo Simulation
Professor, School of
Pharmacy
10/29/2008 Jerry Nick, MD
Neutrophil-induced
enhancement of
Pseudomonas aeruginosa
biofilms
Assistant Professor,
Division of Pulmonary
Medicine, National
Jewish Center
12/3/2008
Donald Gilden,
MD
Professor, Department of
Microbiology, UC Denver
2007
Date
Speaker
Topic
Affiliation/Contact
1/11/2007
Elizabeth
Connick, M.D.
Primary HIV-1 Infection
UCD
1/18/2007
Edward Chan,
M.D.
The skinny on
Mycobacterium abscessus
infection
UCD
2/1/2007
Thomas
HHV-8 Infection and
Campbell, M.D. Kaposi’s Sarcoma
2/15/2007
Peter Palese
2/22/2007
Prevention of HIVEd Janoff, M.D. associated Bacterial
Pneumonia
3/8/2007
Gary Doern,
M.D.
Methicillin Resistant
Staphylococcus aureus –
The Coming Storm
University of Iowa
4/5/2007
Shannon
Kasperbauer,
M.D.
Pulmonary Mycobacterium
Avium Complex
UCD
4/12/2007
Timothy
Jenkins, M.D.
Evaluation and Classification
of Staphylococcus aureus
UCD
Bacteremia
4/19/2007
John Quinn,
M.D.
Emerging Issues of
Resistance in GramNegative Bacteria
4/26/2007
Caring for
Sondra Crosby,
Refugee/Immigrant Women
M.D.
with HIV
Boston University Medical
Center
5/3/2007
Joseph Morroni, Biofilms: not just a sticky
M.D.
mess
UCD
5/10/2007
David
Treatment of Viral
Beckham, M.D. Encephalitis
UCD
5/17/2007
Judith Currier,
M.D.
Atherosclerosis and
Metabolic Complications of
HIV Infection
5/31/2007
Kristin
Brousseau,
D.O.
Cognitive Impairment in the
UCD
Aging HIV+ Patient
8/16/2007
Eoin Coakley,
MD
Influenza Virus Pandemics:
Past and Future
UCD
Mount Sinai School of
Medicine
UCD
Professor of Medicine, Rush
University
Tim Gill Lecture
Senior Medical Director,
Clinical Research, The
Royal College of Surgeons,
Dublin, Ireland
9/6/2007
William
Burman, MD
New TB Medications
Denver Health, UC Denver
9/13/2007
Priscilla Hsue,
MD
HIV and Cardiac Disease
HCSF
9/27/2007
Mark Schaefer,
ParmD
Personalized Medicine: Are
We There Yet?
GSK, Group Director HIV
10/4/2007
Derrick Fine,
MD
HIV and Kidney Disease
Johns Hopkins University
Infection Control
Johns Hopkins University
10/18/2007 Trish Perl, MD
11/1/2007
Bruce Mc
Collister, MD
Antibiotic Tolerance
UC Denver
11/8/2007
Amiee Zaas,
MD
Treating Invasive Fungal
Infections in The
Immunocompromised
Patient
Duke University
Lionel Mandell,
11/15/2007
MD
12/6/2007
The New ATS/IDSA
Guidelines for the
McMaster University
Management of CommunityAcquired Pneumonia
Future Directions for MRSA
Daniel Perlman, Infections/New Diagnostic
MD
Tools and New
Antimicrobials
Greater Denver Infectious
Disease Specialists
2006
Date
Speaker
Title
Affiliation
1/5/2006
Randall
Reeves, M.D.
The Skinny on TB: Anorexia,
Debility, Nutrition or Phenotypic UCD/DHHA
Risk Factors?
1/12/2006
Stanley Louie,
Ph.D.
Clinical Impact of Blockade
Cellular Transporters in HIV
Arena
2/2/2006
Marilyn Levi,
M.D.
BK polyomavirus and
transplantation
UCD
2/16/2006
Ches
Thompson,
M.D.
Epidemiology and Clinical
Burden of Human
Papillomavirus (HPV)
UCD
2/23/2006
Mary Ann
DeGroote
MapQuest, the enduring hunt
for M. paratuberculosis in
Crohn's
UCD
3/2/2006
Herbert
DuPont, M.D.
New Developments in Travelers'
University of Houston
Diarrhea
3/9/2006
HIV Neurobehavioral
Management of Central Nervous
Scott Letendre,
Research Center and
System Complications of HIV
M.D
Antiviral Research
Infection
Center, UCSD
3/30/2006
Peter A Leone,
MD
4/6/2006
Lyle R.
Petersen, M.D., West Nile Virus in the Americas
M.P.H.
4/13/2006
Robert
Bonomo, M.D.
4/20/2006
Richard Martin, Asthma is an infectious
Ph.D
disease.”
4/27/2006
Milene
Management of Patients with CF UCD
Saavedra, M.D.
5/4/2006
The MTCT-Plus Program:
Lessons Learned and Practical
Wafaa El-Sadr,
Aspects of Antiretroviral
M.D., MPH
Therapy in Resource-Poor
Settings
Harlem Hospital and
Columbia U
5/11/2006
Ellie
Schoenbaum,
Montefiore Medical
Center/Albert Einstein
The North Carolina Acute HIV
Program: Screening and
Tracing the Transmission of
HIV
Antimicrobial Resistance and
the Management of Serious
Infections
Menopause and Beyond: HIV in
Older Women
UNC-Chapel Hill
Division of Vector-borne
Infectious Diseases,
Center for Disease
Control and Prevention
Case Western Reserve
School of Medicine
National Jewish Medical
and Research Center
MD
College of Medicine
5/18/2006
Lisa Young,
M.D.
UCD
6/1/2006
Amie Meditz,
M.D.
Projects Exploring Why Women
Have Lower HIV-1 Viral Loads
Early in Disease
UCD
6/8/2006
David
Mechanisms of Disease in Viral
Beckham, M.D. Encephalitis
UCD
6/22/2006
Myron Levin,
M.D.
Herpes Zoster: Pathogenesis
and Prevention
UCD
9/7/2006
Connie Price,
M.D.
The Dying Prosthesis…and other
Dilemmas in Orthopedic Device- UCD/DHHA
Related Infections
9/14/2006
Whitney High,
M.D.
Tropical Medicine and
Cutaneous Disease in the
Returning Traveler
UCD
9/21/2006
Kieran Marr,
M.D.
Fungal Infections in
Immunocompromised Adults
University of
Washington
10/5/2006
Mark Abzug,
M.D.
The Enteroviruses: An Emerging
UCD
Infectious Disease
10/19/2006
Peter ChinHong, M.D.
HPV in MSM
UCSF
10/26/2006
Michelle
Roland, M.D.
Post-exposure Prophylaxis
UCSF
11/2/2006
Jeff Lennox,
M.D.
Research Strategies to care for
the Impossibly Difficult Patient
Emory University
11/16/2006
Andy Zolopa,
M.D.
HIV Resistance and Clinical
Implications
Stanford University
12/7/2006
Dale Gerding,
M.D.
C. difficile
Loyola University
2005
Date
Speaker
Title
Affiliation
1/6/2005
Kathyrn
Holmes, Ph.D.
SARS Update 2005
UCD
1/20/2005
Michael Wong,
M.D.
Update in SOT in HIV+ Recipients
ID Beth Israel
Deaconess/Harvard
1/27/2005
Sarah Parker,
M.D.
Vaccines and autism: understanding
UCD
the controversy
2/3/2005
Alicia Cronquist Foodborne Disease Epidemiology
CDPHE
2/10/2005
Cara Wilson,
M.D.
Update of the EP-1090 HIV-1 DNA
Therapeutic Vaccine Trial
UCD
2/17/2005
Monica Carten,
M.D.
HIV Post-Exposure Prophylaxis for
nonoccupational exposures
UCD
3/3/2005
Susan
Metabolic Complications of HIV
Swindells, M.D. Disease and Its Therapies
University of Nebraska
3/10/2005
Princy Kumar,
M.D.
Georgetown University
3/17/2005
Leland Shapiro, Anthrax! Bacterial Pathogenesis and
UCD
M.D.
Novel Approach to Treatment
3/31/2005
Megan Clancy,
M.D.
Clostridium difficile…Fact and Fiction UCD
4/14/2005
Alison Elliott,
M.D.
The impact of helminth infection in
pregnancy on the response to
immunisation and on disease
incidence in infancy: preliminary
results from a continuing
intervention trial.
London School of
Hygiene and Tropical
Medicine
4/21/2005
Bob Belknap,
M.D.
the Law & Order of TB Control in
2005
UCD
5/5/2005
Kathryn
Robertson,
M.D.
"Dendritic Cell Phenotype and
UCD
Function in HIV-1-infected Patients"
5/12/2005
Ruth Berggren,
MD
Sealing it up and rolling it out: HIV
care in resource poor countries.”
Tulane University
5/19/2005
Mark Abzug,
M.D.
Pneumococcal Vaccination and
Immune Reconstitution in HIVInfected Children
UCD
5/26/2005
Ed Gardner,
M.D.
"Is Risk-Based HIV Testing
Effective? New Data from Denver
Health"
UCD
6/2/2005
Pam Skinner,
PhD
In situ analysis of HIV and SIV
specific CD8+ T cells
University of
Minnesota
HIV as a Chronic Disease
6/9/2005
Mark Cotton,
M.B.
HIV in children from the Western
Cape, South Africa – from bad to
worse to better
6/16/2005
William
Burman, M.D.
"You can't always get what you
want, but if you try sometimes... - a
UCD
clinician's view of salvage
antiretroviral therapy"
6/23/2005
Amie Meditz,
M.D.
Sex Differences in Plasma HIV-1
Concentrations: A pilot study to
investigate HIV-1 Replication and
CCR5 Expression in Lymphoid
Tissue of Women compared to Men
UCD
9/2/2005
Gary Dubin,
M.D.
HPV Vaccine
GSK
9/8/2005
Kees
Rietmeijer,
M.D.
Lymphogranuloma venerum among
Men Who Have Sex With Men
Denver Public Health
9/22/2005
Maggie
Wierman, M.D.
Metabolic Bone Disease in HIV
patients
UCD/Denver VAMC
9/29/2005
Cytomegalovirus Infection in the
Adriana
Era of HAART: Better Immunity and UCD
Weinberg, M.D.
Fewer Reactivations
Stanley
10/20/2005 Derezinski,
M.D.
Minimizing Antibiotic Resistance:
The Fluoroquinolones.
Stellenbosch
University
Stanford
Immunotherapy for Invasive Fungal
Infections: Is There a Role in
Univ of AL
Clinical Care?
10/27/2005
Peter Pappas,
M.D.
11/3/2005
Mary Bessesen,
Nosocomial Aspergillosis
M.D.
UCD
11/17/2005
Greg Everson,
M.D.
UCD
Antiviral Therapy of Advanced
Hepatitis C: Pros and Cons
2004
Date
Speaker
Title
Affiliation
1/8/2004
Philip Keiser,
M.D.
Utility of Cohort Comparisons of AntiUT Southwestern
retroviral Regimens
1/15/2004
Jack Stapleton, GB Virus: A Major Factor in HIV
M.D.
Long Term Nonprogression
Univ of Iowa
1/29/2004
Kevin High,
M.D.
Infection and Immunity in Older
Adults
Wake Forest
University
2/5/2004
Norbert
Voelkel
Expression of HHV-8 in Primary
Pulmonary Hypertension
UCD
2/19/2004
Kathryn Lee,
M.D.
Resistant CMV in BMT Recipients
UCD
3/4/2004
Marin Kollef,
M.D.
Optimization of the antibiotic therapy Washington
for hospital-asasociated pneumonia
University
3/18/2004
Megan Clancy,
M.D.
Community and Hospital Acquired
MRSA Infections at Denver Health
UCD
4/1/2004
Henry F.
Chambers,
M.D.
Community MRSA
UCSF
4/8/2004
Current Concepts on the
Todd Kingdom,
Pathophysiology of Chronic
M.D.
Rhinosinusitis
4/15/2004
Ken Thomson,
Ph.D.
4/22/2004
Susan Cu Uvin, Gynecological Care: Concerns of HIVBrown University
MD
Infected Women
Academic Perspectives in Emerging
Issues of Resistance in GramNegative Bacteria
UCD
University of
Nebraska
4/29/2004
Bill Burman,
M.D.
Invasive nocardiosis - Can we ever
move beyond anecdotes in the
treatment of unusual, but severe
infectious diseases?
5/20/2004
David Wyles,
M.D.
HCV/HIV Co-infection Update and
Beyond: In Vitro Activity and
resistance to a HCV Serine Protease
Inhibitor
5/27/2004
Andrew Pavia,
M.D.
Women, pregnancy and HIV: What
University of Utah
have we learned in the last 10 years.
6/3/2004
John Koeppe,
M.D.
HIV-1 specific T cell Responses in
Viral Evolution – A Major Cause of
Disease Progression?
UCD
6/10/2004
Ed Gardner,
M.D.
Adherence to Antiretrovirals in the
Denver Health System
UCD
6/17/2004
Bruce Walker,
UCD
UCD
Harvard University
M.D.
6/24/2004
Robert
Belknap, M.D.
Tuberculosis Elimination: the
Colorado Perspective
UCD
9/9/2004
Michael Miller,
Ph.D.
Resistance, Replication Capacity and
Intracellular Pharmacology of NRTIs
Gilead
9/16/2004
Arturo
Casadeval,
M.D., Ph.D
'New insights into cryptococcal
pathogenesis and development of
antibody therapy'
Albert Einstein
College of Medicine
9/23/2004
J.J. Hakim,
M.D.
Impact of HIV Epidemic on Clinical
Practice in Zimbabwe
Tim McGill Annual
Lecture
10/7/2004
Connie Price,
M.D.
Science and Superstitions in
Infection Control
UCD
10/14/2004
Jo-Anne van
Burik, M.D.
Antifungal prophylaxis: Clinical
updates
Univ of Minnesota
Elizabeth
10/21/2004
Connick, M.D.
Why Have Efforts To Augment HIVSpecific Immunity Failed to Result in
UCD
Virologic Control? New Insights From
Lymphoid Tissue Studies
10/28/2004
Michelle
Barron, M.D.
11/4/2004
Michael
Interesting Case Presentations from
Saubolle, Ph.D. the Southwest Deserts
11/11/2004
Mike Pfaller,
M.D.
Has Antifungal Testing Come of Age? University of Iowa
11/18/2004
John Perfect,
M.D.
Advancing the Art of Antifungal
Therapy: New Therapeutic Options
and Strategies
12/2/2004
Chris
Petropoulos,
Ph.D.
A Closer Look at HIV-1 Co-Receptor
Tropism in the Emerging Era of Entry Virologic Labs
Inhibitors
12/9/2004
Alan T.
Evangelista,
Ph.D.
Antimicrobial Resistance Trends and
Appropriate use of Antibiotics
Influenza in the 21st Century
UCD
University of
Arizona
Duke University
Ortho-McNeil
Pharmaceuticals
2003
Date
Speaker
Title
Affiliation
1/9/2003
Thomas
Patterson
New Antifungal Agents: New
Choices
UTHSC-SA
1/16/2003
Dennis Maki
The Need for a New Paradigm for
Control of Nosocomial Infection in
the ICU
Univ of Wisconsin
1/23/2003
Frank Judson
Bioterrorism: A Holistic Approach
to Assessing Risk and Planning for
Control
UCD
1/30/2003
Steven Johnson
West Nile Virus
UCD
2/6/2003
Ed Abraham
New Treatments for Sepsis
UCD
2/20/2003
Judith Andersen
History of the Plague
UCD
2/27/2003
Nalini Rao
An Update on the Diagnosis and
Management of Osteomyelitis
University of
Pittsburgh
3/6/2003
Donna Sweet
HIV care: A Perspective on Women
University of
Kansas
3/13/2003
Dan Kuritzkes
HIV Drug Resistance: Strategic
Implications for Therapy
Harvard
University
4/3/2003
Veronica Miller
Definition of Treatment Failure
George
Washington
University
4/10/2003
Ferric Fang
Can We Treat Infectious Diseases
by Modulating Host Defenses?
University of
Washington
4/17/2003
Joseph
Falkinham
Epidemiology and Ecology of
Mycobacterium avium
Virginia
Polytechnic
University
4/24/2003
Kathleen Squires
Clinical Care Update: Antiretroviral
USC
Therapies for Women
5/1/2003
John Koeppe
Mechanism of CD4+ T cell escape
UCD
5/8/2003
Bill Burman
Why isn't TB going away in
Denver? Insights from
conventional and molecular
epidemiology
UCD
5/15/2003
James Neid
KSHV infection of pulmonary
endothelial cells: clinical and
laboratory significance
UCD
Mary Hamel
The Effect of Daily Cotrimoxazole
for the Prevention of HIV-Related
Opportunistic Infections on the
Development of Resistance in
Common Pathogens in Africa
CDC
5/22/2003
5/29/2003
David Wyles
“Toward an in vitro system to
characterize novel anti-HCV
compounds
UCD
6/5/2003
Mark Thrun
HIV Prevention: Moving Beyond
Condoms
UCD
6/12/2003
Bruce
McCollister
Interferon-gamma in host defense
against S. typhimurium
UCD
6/19/2003
Kathryn Lee
CMV-Specific Immune
Reconstitution in BMT Patients
UCD
6/26/2003
"Specific anti-cytokine therapies
work but at the expense of
Charles Dinarello
decreased host defense against
infection."
9/4/2003
Richard Ogden,
Ph.D.
HIV Resistance, Fitness, and
Pathogenicity: Current Data and
Ongoing Research
Agouron
9/11/2003
Mike Iseman,
M.D.
Primum Non Nocere and RIF-PZA
Treatment of Latent TB: Mutually
Exclusive?"
UCD
9/25/2003
Mark Sulkowski,
M.D.
HCV in the HIV-infected Patient
Johns Hopkins
10/2/2003
Mahmoud A.
Ghannoum,
M.Sc., Ph.D.
Candida Biofilms and the Role of
Antifungals
Case Western
10/16/2003
David Simpson,
M.D.
Neurological Complications of HIV
Mt. Sinai
10/23/2003
S. Ferrando,
M.D.
Case Studies in HIV
Cornell University
10/30/2003
Evolving Epidemiology of Fungal
Dimitrios
Infections with a Special Focus on
Kontiannis, M.D.
Candidemia
MD Anderson
11/6/2003
Ken
Lichtenstein,
M.D.
Antiretroviral Toxicities, An
Alternative View
Rose Medical
Center
11/13/2003
Max Salfinger,
M.D.
HIV/TB Co-Infection Up-Date
NY State Dept of
Health
11/20/2003
Nelson Gantz,
M.D.
Chronic Fatigue Syndrome: Real or
UCD/Boulder
Imaginary
12/4/2003
Ken Tyler, M.D.
West Nile Virus
UCD
Nucleoside Therapy in 2003; What
Have We Learned and Where do
we go From Here?
GSK
12/11/2003 Marty St. Clair
UCD